drugset / Trial / NCT00919490
A Study of Single Dose of ABT-333 in Healthy Male Adults
RandomizedSingle-groupDouble-blindTreatment
Summary
The objectives of this study is to assess the safety, tolerability, and pharmacokinetics of blind, escalating, single, oral doses of ABT-333 under nonfasting conditions in healthy male adult in Japan.
Timeline
- Start
- 2009-06
- Primary completion
- 2009-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | dasabuvir | Small molecule | 400 mg | Oral |
| Subject | dasabuvir | Small molecule | 800 mg | Oral |
| Subject | dasabuvir | Small molecule | 1200 mg | Oral |
| Subject | dasabuvir | Small molecule | 1600 mg | Oral |